Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorbitol and mannitol injection vs mannitol injection for intracranial hypertension
CTR20244329Phase 3Active
- Sponsor
- Shijiazhuang No. 4 Pharmaceutical
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorbitol + mannitol in intracranial hypertension (IH), cerebral edema, traumatic brain injury (TBI), cerebrovascular disease, sponsored by Shijiazhuang No. 4 Pharmaceutical. Started Nov 2024; status: active.
02
Drugs
sorbitol + mannitol
03
Conditions
intracranial hypertension (IH)cerebral edematraumatic brain injury (TBI)cerebrovascular disease
Beyond the preview
Go deeper on CTR20244329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244329.